Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-κB activity via direct interaction with p50

Molecular Cancer Therapeutics

Volumn 8, Issue 6, 2009, Pages 1613-1624

  Jung, Ok Ban ^a   Ju, Hoon Oh ^a   Bang, Yeon Hwang ^a   Dong, Cheul Moon ^a   Jeong, Heon Sang ^a   Lee, Seram ^b   Kim, Soyoun ^b   Lee, Hyosung ^c   Kim, Kyung Bo ^c   Sang, Bae Han ^a   Jin, Tae Hong ^a  

^a Chungbuk National University   (South Korea)

^b Dongguk University   (South Korea)

^c University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DITHIOTHREITOL; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLEXINOL; KAURANE DERIVATIVE; MUTANT PROTEIN; PROTEIN P50; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCHIP; CANCER GROWTH; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DITERPENES, KAURANE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HCT116 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; NITRIC OXIDE SYNTHASE TYPE II; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-BCL-2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 67649360284     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-08-0694     Document Type: Article

References (48)

1. Baeuerle PA, Baltimore DA. 65-κD subunit of active NF-κB is required for inhibition of NF-κB by I κB. Genes Dev 1989;3:1689-1698
2. Ballard DW, Dixon EP, Peffer NJ, et al. The 65-kDa subunit of human NFκB functions as a potent transcriptional activator and a target for v-rel-mediated repression. Proc Natl Acad Sci U S A 1992;89:1875-1879
3. Schmitz ML, Baeuerle PA. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J 1991;10:3805-3817 (Pubitemid 21905409)
4. Baldwin AS, Jr.. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649-683
5. Olivier S, Robe P, Bours V. Can NF-κB be a target for novel and efficient anti-cancer agents? [review]. Biochem Pharmacol 2006;72:1054-1068
6. Lind DS. NF-κB is upregulated in colorectal cancer. Surgey 2001;130:363-369
7. Hardwick JC, Van den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP. NF-κB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene 2001;20:819-827 (Pubitemid 32198175)
8. Karin M, Cao Y, Greten FR, Li ZW. NF-κB in cancer: from innocent by stander to major culprit. Nat Rev Drug Discov 2002;2:301-310 (Pubitemid 37328783)
9. Barket M, Gilmore TD. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 1999;18:6910-6924
10. Phal HL. Activators and target genes of Rel/ NF-κB transcription factors. Oncogene 1999;18:6853-6866
11. Wahl C, Liptay S, Adler G, Schmid RM. Sulfasalazine: a potent and specific inhibitor of nuclear factor κB. J Clin Invest 1998;101:1163-1174 (Pubitemid 28125296)
12. Din FV, Dunlop MG, Stark LA. Evidence for colorectal cancer cell specificity of aspirin effects on NF-κB signaling and apoptosis. Br J Cancer 2004;91:381-388 (Pubitemid 39037087)
13. Boolbol SK. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 1996;56:2556-2560 (Pubitemid 26171681)
14. Takada Y, Bhardwaj A, Potdar P, Aggarwal BB. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene 2004;23:9247-9258 (Pubitemid 40069695)
15. Surh YJ, Chun KS, Cha HH, et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: downregulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat Res 2001;480-1:243-268 (Pubitemid 32744832)
16. Takada Y, Andreeff M, Aggarwal BB. Indole-3-carbinol suppresses NF-κB and IκBα kinase activation, causing inhibition of expression of NF-κB-regulated anti-apoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood 2005;106:641-649 (Pubitemid 40981262)
17. Jung BS, Shin MK. Encyclopedia of illustrated korean natural drugs. Seoul: Young Lim Sa; 1990. p. 845-846
18. Sun HD, Huang SX, Han QB. Diterpenoids from Isodon species and their biological activities. Nat Prod Rep 2006;23:673-698
19. Lee JH, Koo TH, Hwang BY, Lee JJ. Kaurane diterpene, kamebakaurin, inhibits NF-κB by directly targeting the DNA-binding activity of p50 and blocks the expression of anti-apoptotic NF-κB target genes. J Biol Chem 2002;277:18411-18420 (Pubitemid 34952387)
20. Nagashima F, Kondoh M, Uematsu T, et al. Cytotoxic and apoptosis-inducing ent-kaurane-type diterpenoids from the Japanese liverwort Jungermannia truncata NEES. Chem Pharm Bull 2002;50:808-813 (Pubitemid 41694899)
21. Hwang BY, Lee JH, Koo TH, et al. Kaurane diterpenes from Isodon japonicus inhibit nitric oxide and prostaglandin E2 production and NF-κB activation in LPS-stimulated macrophage RAW264.7 cells. Planta Med 2001;67:406-410 (Pubitemid 32652574)
22. Lee JW, Kim TH, Hong SS, Hwang BY, Ro JW, Hong JT. Inhibitory effect of inflexinol on nitric oxide generation and iNOS expression via inhibition of NF-κB activation. Mediators Inflamm 2007;2007:93148. (Pubitemid 46987647)
23. Lin X, O'Mahony A, Mu Y, Geleziunas R, Greene WC. Protein kinase Cθ participates in NF-κB activation induced by CD3-28 costimulation through selective activation of IκB kinase β. Mol Cell Biol 2000;20:2933-2940 (Pubitemid 30183513)
24. Son DJ, Park MH, Chae SJ, et al. Inhibitory effect of snake venom toxin from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth: induction of apoptosis through inactivation of nuclear factor κB. Mol Cancer Ther 2007;6:675-683 (Pubitemid 46332468)
25. Lee S, Kim YS, Jo M, Jin M, Lee DK, Kim S. Chip-based detection of hepatitis C virus using RNA aptamers that specifically bind to HCV core antigen. Biochem Biophys Res Commun 2007;358:47-52. (Pubitemid 46719079)
26. Park HJ, Lee SH, Son DJ, et al. Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-κB through interaction with the p50 subunit. Arthritis Rheum 2004;50:3504-3515 (Pubitemid 39488675)
27. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Jr., Sledge GW, Jr. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 1997;17:3629-3639
28. Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem Sci 2005;30:43-52. (Pubitemid 40093740)
29. Yu LL, Yu HG, Yu JP. Nuclear factor-κB p65 (RelA) transcription factor is constitutively activated in human colorectal carcinoma tissue. World J Gastroenterol 2004;10:55-60.
30. Fantini MC, Pallone F. Cytokines: from gut inflammation to colorectal cancer. Curr Drug Targets 2008;9:375-380 (Pubitemid 352025211)
31. Suzuki I, Kondoh M, Nagashima F, Fujii M, Asakawa Y, Watanabe Y. A comparison of apoptosis and necrosis induced by ent-kaurene type diterpenoids in HL-60 cells. Planta Med 2004;70:401-406 (Pubitemid 38716471)
32. Hsieh TC, Wijeratne EK, Liang JY, Gunatilaka AL, Wu JM. Differential control of growth, cell cycle progression, and expression of NF-κB in human breast cancer cells MCF-7, MCF-10A, and MDA-MB-231 by ponicidin and oridonin, diterpenoids from the Chinese herb Rabdosia rubescens. Biochem Biophys Res Commun 2005;337:224-231 (Pubitemid 41393783)
33. Hong SS, Lee SA, Han XH, et al. Kaurane diterpenoids from Isodon excisus inhibit LPS-induced NF-κB activation and NO production in macrophage RAW264.7 cells. J Nat Prod 2007;70:632-636 (Pubitemid 46797869)
34. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and anti-apoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation. Mol Pharmacol 2006;69:195-206. (Pubitemid 43048906)
35. Gupta S, Hastak K, Afaq F, Ahmad N, Mukhtar H. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor κB and induction of apoptosis. Oncogene 2004;23:2507-2522 (Pubitemid 38520748)
36. Dorai T, Aggarwal BB. Role of chemopreventive agents in cancer therapy. Cancer Lett 2004;215:129-140 (Pubitemid 39370030)
37. Wang L, Zhao WL, Yan JS, et al. Eriocalyxin B induces apoptosis of t (8;21) leukemia cells through NF-κB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner. Cell Death Differ 2007;14:306-317 (Pubitemid 46092233)
38. Lee SH, Lee CW, Lee JW, et al. Induction of apoptotic cell death by 2′- hydroxycinnamaldehyde is involved with ERK-dependent inactivation of NF-κB in TNF-α-treated SW620 colon cancer cells. Biochem Pharmacol 2005;70:1147-1157 (Pubitemid 41317509)
39. Lee SY, Yuk DY, Song HS, et al. Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NF-κB. Eur J Pharmacol 2008;582:17-25.
40. Sun HD, Huang SX, Han QB. Diterpenoids from Isodon species and their biological activities. Nat Prod Rep 2006;23:673-698
41. Leung CH, Grill SP, Lam W, Han QB, Sun HD, Cheng YC. Novel mechanism of inhibition of nuclear factor-κB DNA-binding activity by diterpenoids isolated from Isodon rubescens. Mol Pharmacol 2005;68:286-297 (Pubitemid 41058292)
42. Cernuda-Morollon E, Pineda-Molina E, Canada FJ, Perez-Sala D. 15-Deoxy-Δ 12,14-prostaglandin J2 inhibition of NF-κB-DNA binding through covalent modification of the p50 subunit. J Biol Chem 2001;276:35530-35536
43. Kapahi P, Takahashi T, Natoli G, et al. Inhibition of NF-κB activation by arsenite through reaction with a critical cysteine in the activation loop of IκB kinase. J Biol Chem 2002;275:36062-36066
44. Jeon KI, Byun MS, Jue DM. Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunit. Exp Mol Med 2003;35:61-66 (Pubitemid 36626935)
45. Ciucci A, Gianferretti P, Piva R, et al. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IκB kinase/nuclear factor-κB pathway. Mol Pharmacol 2006;70:1812-1821 (Pubitemid 44776441)
46. Dal Piaz F, Nigro P, Braca A, De Tommasi N, Belisario MA. 13-Hydroxy- 15-oxo-zoapatlin, an ent-kaurane diterpene, induces apoptosis in human leukemia cells, affecting thiol-mediated redox regulation. Free Radic Biol Med 2007;43:1409-1422 (Pubitemid 47532364)
47. Yu ZY, Liang YG, Xiao H, et al. Melissoidesin G, a diterpenoid purified from Isodon melissoides, induces leukemic-cell apoptosis through induction of redox imbalance and exhibits synergy with other anti-cancer agents. Int J Cancer 2007;121:2084-2094 (Pubitemid 47463174)
48. Ikezoe T, Yang Y, Bandobashi K, et al. Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-κB signal pathways. Mol Cancer Ther 2005;4:578-586 (Pubitemid 40601839)